InvestorsHub Logo

surf1944

12/12/12 9:37 AM

#881 RE: surf1944 #874

8:31AM YM BioSciences to be acquired by Gilead Sciences (GILD) for $2.95 per share in cash (YMI) 1.63 : The transaction has received the unanimous approval of YM's Board of Directors, and values YM at ~ $510 million, with YM reporting CAD125.5 million in cash and cash equivalents as of Sep 30, 2012. Gilead plans to fund the acquisition with cash on hand. The transaction is expected to close in the first quarter of 2013.